Protection | Effect | Mechanism | References |
---|
Vascular disease | antioxidant |
↓ LDL oxidation | [24],[49],[50] |
| |
↓ Lipid peroxidation | [51] |
| ↓ endothelial activation |
↓ VCAM-1 | [53] |
| ↓ monocyte adhesion | | |
| ↓ platelet aggregation | n.d. | [54] |
| | ↓COX-2 activity | [55] |
| | ↓thromboxane A2 | |
| | ↑NO | |
| ↓ VSME proliferation | ↓ERK 1/2 phosphorylation | [56] |
Heart disease | ↓ coronary occlusion (*) |
↓ CK activity | [57] |
| |
↓ GSSG | |
| ↓ cardiotoxicity (**) | ↑AMPK phosphorylation | [58],[59] |
| | ↓iNOS expression | |
| |
↑ METC activity | |
| ischemia | hypolipidemia | [61] |
| | ↓SOD activity | |
| myocardial infarction |
↑ Akt phosphorylation | [62] |
| |
↑ eNOS phosphorylation | |
| |
↑ FOXO3a phosphorylation | |
- (*) myocardial injury induced by ischemia; (**) DXR-induced toxicity; n.d.: not determined.
-
Abbreviations: AMPK 5’-AMP-activated protein kinase; CK Creatine kinase; COX cyclooxygenase; DXR doxorubicin; eNOS endothelial nitric oxide synthase; ERK extracellular regulated kinase; GSSG Oxidize glutathione; iNOS inducible nitric oxide synthase; LDL low-density lipoproteins; MMP matrix metalloproteinases; METC mitochondrial electron transport chain; NO nitric oxide; PDE phosphodiesterase; SOD superoxide dismutase; VCAM vascular adhesion molecule; VSME vascular smooth muscle cells.